Some HIV-1 carriers who have received an early antiretroviral treatment during several years are able to control the virus for a long term after treatment interruption. However, the mechanisms ...

The trial evaluated treatment responses in patients who were virologically suppressed, switching from a multi-tablet regimen ...

Gilead Sciences (GILD) announced on Thursday that its Phase 3 ARTISTRY-1 trial, which tested its new single-tablet regimen of ...

In a recent study published in the Advanced Science journal, researchers assessed the effectiveness of synthetic mucin gels in the inhibition of human immunodeficiency virus-1 (HIV-1) and herpes ...

The ability to diagnose an acute HIV-1 infection before there are detectable antibodies to HIV 1/2 is critical to making an early diagnosis and getting the individual into treatment. Approximately ...

In a recent study posted to Research Square* preprint server, researchers assessed the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and SARS-CoV envelope (E) proteins on ...

The performance characteristics of a sequential rapid HIV-testing algorithm were poorer than anticipated in a Ugandan study, perhaps due to false-positive results from tests with "faint bands." Rapid ...

Table 3. Summary of case series and cohort studies describing response of HIV-1/2 dual-infected patients on ART in the HAART era. Individual case reports excluded, but are discussed in the main text.